Gulnur Sh Burbaeva

Gulnur Sh Burbaeva

Auto-generated profile, based on publicly available information

Gulnur Sh Burbaeva

Mental Health Research Center

Research Focus & Metrics

Academic Career Length

59Years (1968-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
GBGulnur Sh. Burbaeva
Gulnur Sh. Burbaeva
IBIrina S. Boksha
Irina S. Boksha
MTMarina S. Turishcheva
Marina S. Turishcheva
EVElena A. Vorobyeva
Elena A. Vorobyeva
OSOlga K. Savushkina
Olga K. Savushkina
ETElena B. Tereshkina
Elena B. Tereshkina

1 November 2005 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
GBGulnur Sh. Burbaeva
Gulnur Sh. Burbaeva
IBIrina S. Boksha
Irina S. Boksha
ETElena B. Tereshkina
Elena B. Tereshkina
OSOlga K. Savushkina
Olga K. Savushkina
LSLubov’ I. Starodubtseva
Lubov’ I. Starodubtseva
MTMarina S. Turishcheva
Marina S. Turishcheva

11 February 1991 in FEBS Letters
Verified
Journal Article
Closed access
MAM.V. Aksenova
M.V. Aksenova
GBG.SH. Burbaeva
G.SH. Burbaeva
KKK.V. Kandror
K.V. Kandror
DKD.V. Kapkov
D.V. Kapkov
ASA.S. Stepanov
A.S. Stepanov

21 June 2014 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
GBG. Sh. Burbaeva
G. Sh. Burbaeva
IBI. S. Boksha
I. S. Boksha
ETE. B. Tereshkina
E. B. Tereshkina
OSO. K. Savushkina
O. K. Savushkina
TPT. A. Prokhorova
T. A. Prokhorova
EVE. A. Vorobyeva
E. A. Vorobyeva

1 January 2003 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
GBGulnur Sh. Burbaeva
Gulnur Sh. Burbaeva
OSOlga K. Savushkina
Olga K. Savushkina
IBIrina S. Boksha
Irina S. Boksha
Creatine kinase (CK) is responsible for the creatine/ creatine phosphate level, which is known to alter in the brain of patients with schizophrenia. A comparative estimation of CK enzymatic activity and immunoreactivity of CK BB was carried out in readily soluble extracts from frontal cortex, anterior and posterior cingulate cortex, hippocampus and cerebellum from brains of individuals with schizophrenia versus normal controls. CK activity was determined using a commercial diagnostic kit. CK BB immunoreactivity was evaluated by ECLimmunoblotting using monoclonal antibody. A drastic drop of CK activity and CK BB immunoreactivity was observed in all the examined brain areas in schizophrenic patients compared to controls (p>0.01), with the maximum drop in the cerebellum. The reduction was independent of age, postmortem interval or chlorpromazine equivalent. The decreased level of CK BB in schizophrenia was confirmed by purification of CK BB from brains of patients with schizophrenia and control brains: the yield of the purified enzyme was significantly lower in schizophrenia, wherein molecular masses of CK B-subunits were equal. Possible causes and consequences of the decrease in CK BB level observed in brain of patients with schizophrenia are discussed.

1 December 2000 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
IBIrina S. Boksha
Irina S. Boksha
ETElena B. Tereshkina
Elena B. Tereshkina
GBGulnur Sh. Burbaeva
Gulnur Sh. Burbaeva
Glutamine synthetase (GS; EC 6.3.1.2), a key enzyme ofglutamate metabolism, and another enzyme possessing highhydroxylamine‐L‐glutamine transferase activity comparable to that of GS andtermed GS‐like protein (GSLP) were purified from human brain concurrently. Intwo‐dimensional electrophoresis, GS subunits migrate to at least six differentpositions (44 ± 1 kDa, pl = 6.4‐6.7), whereas GSLP subunits migrate toat least four different positions (54 ± 1 kDa, pl = 5.9‐6.2).Dependences of enzymatic activity in the transferase reaction onconcentrations of Mn2+ and Mg2+ for GS and GSLP aredifferent. High immunological cross‐reactivity between GS and GSLP wasobserved in ELISA. Nevertheless, antisera were raised to GS and GSLP, and amethod was developed for the separate detection of GS and GSLP in brainextracts by enzyme‐chemiluminescent amplified (ECL) immunoblotting. Thedistribution of GS and GSLP immunoreactivities between soluble protein andcrude mitochondrial fractions indicates tighter association with theparticulate fraction for GSLP than for GS. The results from activitymeasurements suggest that the hydroxylamine‐L‐glutamine transferase activitymeasured routinely in protein extracts from brain is the sum of GS and GSLPactivities. Similarly, immunoreactivity evaluated by ELISA is a sum ofimmunoreactivities of GS and GSLP. The relative contributions of GS and GSLPto the total immunoreactivity can be evaluated by ECL‐immunoblotting.